Development of Therapeutic Medical Countermeasures for Biodefense
$127,822N01FY2016AINIH
Aridis Pharmaceuticals, Llc, San Jose CA
Investigators
Abstract
This contract supports the advanced development of promising therapeutic candidates with broad spectrum activity against resistant pathogens. The research and development activities to be supported will allow candidate therapeutic products to progress through the product development pipeline, and includes preclinical and non-clinical activities, as well as IND development activities.
View original record on NIH RePORTER →